科研
教育
解决方案
登录
CN
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Department of Medical Chemistry,
Faculty of Medicine,
Doctoral School of Molecular Medicine,
Department of Medical Chemistry, Faculty of Medicine
Eliza Guti has not added Biography.
If you are Eliza Guti and would like to personalize this page please email our Author Liaison for assistance.
The multitargeted receptor tyrosine kinase inhibitor sunitinib induces resistance of HER2 positive breast cancer cells to trastuzumab-mediated ADCC.
Cancer immunology, immunotherapy : CII Sep, 2022 | Pubmed ID: 35066605
University of Debrecen
Eliza Guti*,1,2,
Ákos Máté Bede*,1,3,
Csongor Váróczy*,1,3,
Csaba Hegedűs1,
Máté Á. Demény1,4,
László Virág1,4
1Department of Medical Chemistry, Faculty of Medicine, University of Debrecen,
2Doctoral School of Molecular Medicine, University of Debrecen,
3National Academy of Scientist Education, University of Debrecen,
4, ELKH-DE Cell Biology and Signaling Research Group
政策
使用条款
隐私
联系我们
向图书馆推荐
JoVE 新闻简报
JoVE Journal
技术专题合集
JoVE Encyclopedia of Experiments
档案
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
教师资源中心
发表
图书馆员
访问权限
关于 JoVE
版权所属 © 2024 MyJoVE 公司版权所有,本公司不涉及任何医疗业务和医疗服务。